Sanofi enters agreement to use E.Coli for expression optimization
Sanofi will use AbSci’s platform to further optimize two of its in-house proteins – and will partner with other companies to accelerate timelines and reduce costs.
Sanofi will use AbSci’s platform to further optimize two of its in-house proteins – and will partner with other companies to accelerate timelines and reduce costs.
Strategikon Pharma releases new modules for its Clinical Maestro software suite – another step in the company’s journey to harmonize sponsor and CRO operations, with further updates slated for later this year, says CCO.
ClinOne uses text messaging and automated reminders to help ensure medication adherence in clinical trials with its new service, DoseMonitor.
Caprion Biosciences will provide mass cytometry services to expand its offerings as a specialty CRO after its acquisition of Primity Bio.
Genetic discoveries have taken place in narrow population groups, say researchers, who for the first time, reveal that such studies are concentrated in a handful of countries – and conducted by a ‘tight-knit group of researchers.’
Lilly France announced 250 positions will be cut from its Fegersheim site but will also invest €100m to update facilities over the coming years.
After a low cost of manufacturing goal was achieved by a consortium for the development of a bioproduction system for vaccines, Univercells will launch its NevoLine system.
Akorn received a warning letter from the FDA on January 4, relating to the inspection of its manufacturing facility in Decatur, Illinois, in April and May 2018.